首頁
Pharma Focus Europe

7月 2026Pharma Focus Europe的市場佔有率分析

Share your pharma industry event with Pharma Focus Europe. Submit your event details to reach a global audience of industry professionals and experts.

行業: N/A

域名pharmafocuseurope.com

成立年份--

僱員51 - 200

年度營收--

Pharma Focus Europe

Pharma Focus Europe（包含公司地區）

pharmafocuseurope.com

查看更多網站流量與參與度資訊

Pharma Focus Europe的熱門網域總造訪量

了解Pharma Focus Europe市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

pharmafocuseurope.com7.2K

透過銷售情報查看更多內容

Pharma Focus Europe的熱門網域平均造訪時長

分析Pharma Focus Europe參與度指標。

過去 3 個月平均造訪時長

子公司細目

pharmafocuseurope.com00:00:35

透過銷售情報查看更多內容

Pharma Focus Europe的熱門網域平均頁面瀏覽量

了解Pharma Focus Europe如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

pharmafocuseurope.com1.67

透過銷售情報查看更多內容

Pharma Focus Europe按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

lvb.com公司名Lehigh Valley Business僱員51 - 200總部美國, 賓夕法尼亞州, Bethlehem年度營收$15M - $25M訪問總量14.5K新聞與媒體發行商

使用的熱門技術Pharma Focus Europe

这些是Pharma Focus Europe顶级域名使用的行业网站技术

付費廣告 (9)

Google Adsense

轉換與分析 (4)

Google Analytics

市場行銷 (3)

Google Marketing Platform

付款與貨幣 (3)

Visa

更多技術

6

檢視所有

新聞與訊號來自Pharma Focus Europe

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Pharmafocuseurope partnered with Pherecydes Pharma, limited on Feb 1st '23.“In February this year, Pharmafocuseurope announced its strategic plans with PHERECYDES, with the intent to build a global leader in phage therapy and address the huge medical need caused by antimicrobial resistance.

新聞Pharmafocuseurope acquired DILIsym Services on Jan 1st '17.When Pharmafocuseurope made the decision to expand into the QSP space in 2017, Pharmafocuseurope acquired DILIsym Services and leveraged their expertise to expand into new therapeutic areas.

新聞Pharmafocuseurope is developing internal/collaborative drug discovery project and drug discovery support services for pharmaceutical companies using Cryo-EM technologies.Currently, Pharmafocuseurope is developing internal/collaborative drug discovery project and drug discovery support services for pharmaceutical companies using its Cryo-EM technologies.